Pacheco-Silva A - Search Results

1

Effect of thymoglobulin in graft survival and function 1 year after kidney transplantation using deceased donors.

Requião-Moura LR, Durão MS, Tonato EJ, Pereira MG, Wroclawski ER, Matos AC, Pacheco-Silva A. Requião-Moura LR, et al. Transplant Proc. 2006 Jul-Aug;38(6):1895-7. doi: 10.1016/j.transproceed.2006.06.064. Transplant Proc. 2006. PMID: 16908315

2

Increased production of beta-2 microglobulin in stable renal transplant patients.

Pacheco-Silva A, Nishida SK, Silva MS, Ramos OL, Ajzen H, Pestana JO, Pereira AB. Pacheco-Silva A, et al. Transplantation. 1995 Mar 27;59(6):914-7. Transplantation. 1995. PMID: 7701593 No abstract available.

3

Monitoring serum beta-2 microglobulin is useful for detecting patients with increased risk of acute rejection during reduction in immunosuppression.

Câmara NO, Nishida S, Silva MS, Pestana JO, Pereira AB, Sesso R, Pacheco-Silva A. Câmara NO, et al. Transplant Proc. 1998 Dec;30(8):4158-9. doi: 10.1016/s0041-1345(98)01378-5. Transplant Proc. 1998. PMID: 9865333 No abstract available.

4

Early detection of heart transplant patients with increased risk of ciclosporin nephrotoxicity.

Câmara NO, Matos AC, Rodrigues DA, Pereira AB, Pacheco-Silva A. Câmara NO, et al. Lancet. 2001 Mar 17;357(9259):856-7. doi: 10.1016/S0140-6736(00)04207-0. Lancet. 2001. PMID: 11265958

5

Urinary retinol binding protein is a good marker of progressive cyclosporine nephrotoxicity after heart transplant.

Camara NO, Matos AC, Rodrigues DA, Pereira AB, Pacheco-Silva A. Camara NO, et al. Transplant Proc. 2001 May;33(3):2129-31. doi: 10.1016/s0041-1345(01)01971-6. Transplant Proc. 2001. PMID: 11377474 No abstract available.

6

Use of reduced dose of OKT3 (2.5 mg) after renal transplantation.

Machado PG, Tedesco HS, Silva RG, Pacheco-Silva A, Medina JO. Machado PG, et al. Transplant Proc. 2002 Feb;34(1):104. doi: 10.1016/s0041-1345(01)02688-4. Transplant Proc. 2002. PMID: 11959207 No abstract available.

7

Five hundred transplants in 500 consecutive days.

Machado PG, Rambalducci S, Garcia R, Kushnaroff LM, Almeida CR, Baptista JC, Gerbase M, Franco M, Pacheco-Silva A, Tedesco H, Medina JO. Machado PG, et al. Transplant Proc. 2002 Mar;34(2):497. doi: 10.1016/s0041-1345(02)02606-4. Transplant Proc. 2002. PMID: 12009602 No abstract available.

8

Adverse effects of pregnancy on renal allograft function.

Miranda CT, Melaragno C, Camara NO, Pacheco-Silva A, Medina-Pestana PJ. Miranda CT, et al. Transplant Proc. 2002 Mar;34(2):506-7. doi: 10.1016/s0041-1345(02)02612-x. Transplant Proc. 2002. PMID: 12009607 No abstract available.

9

Acute rejection is a risk factor for long-term survival in a single-center analysis of 1544 renal transplants.

Galante NZ, Tedesco HS, Machado PG, Pacheco-Silva A, Medina-Pestana JO. Galante NZ, et al. Transplant Proc. 2002 Mar;34(2):508-13. doi: 10.1016/s0041-1345(02)02613-1. Transplant Proc. 2002. PMID: 12009608 No abstract available.

10

Angioplasty with stent is the preferred therapy for posttransplant renal artery stenosis.

da Silva RG, Lima VC, Amorim JE, Machado PG, Pacheco-Silva A, Medina-Pestana JO. da Silva RG, et al. Transplant Proc. 2002 Mar;34(2):514-5. doi: 10.1016/s0041-1345(02)02614-3. Transplant Proc. 2002. PMID: 12009609 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters